Viewing Study NCT03717519



Ignite Creation Date: 2024-05-06 @ 12:14 PM
Last Modification Date: 2024-10-26 @ 12:56 PM
Study NCT ID: NCT03717519
Status: COMPLETED
Last Update Posted: 2023-07-20
First Post: 2018-10-22

Brief Title: Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona
Organization: Azienda Ospedaliera Universitaria Integrata Verona

Study Overview

Official Title: Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases a Retrospective Single-center Cohort Study
Status: COMPLETED
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PLTCRC
Brief Summary: Colorectal cancer CRC is the third most common malignancy worldwide and is often metastatic at diagnosis Despite progresses in surgical techniques and the introduction of novel chemotherapy regimens many patients still suffer from a poor prognosis It is therefore of utmost importance to identify prognostic markers that may improve selection of patients

In recent years several studies demonstrated that preoperative blood tests as platelet count or neuthophil-to-lymphocyte ratio could be prognostic factors in CRC as well as other malignancies The aim of this study was to evaluate the role of preoperative platelet count PC in patients with synchronous colorectal liver metastases
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None